By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Q Therapeutics, Inc. 

Salt Lake City  Utah    U.S.A.
Phone: 801-582-5400 Fax:


Start Up

Company News
Q Therapeutics, Inc. Expands Board Of Directors With Appointment Of Dr. Tom Parks As Independent Member 8/7/2017 8:15:53 AM
Q Therapeutics, Inc. Release: FDA Allows Q-Cells For First-In-Human Transverse Myelitis Trial 7/25/2017 7:52:17 AM
Goodwin Biotechnology, Inc. Announces The Completion Of cGMP Manufacturing Of An IgM Monoclonal Antibody And IgM : Ligand Conjugate For Q Therapeutics, Inc., And Successful Clearance Of Q Therapeutics' IND Submission For Q-Cells Cell Therapy In ALS 7/13/2015 7:20:55 AM
Q Therapeutics, Inc. Release: Novel Cellular Therapeutic Approach For ALS Gets FDA Clearance For First-In-Human Trials 6/4/2015 8:54:56 AM
Q Therapeutics, Inc. Expands Board Of Directors With Appointment Of Dr. Hunter Jackson As Independent Member 9/24/2014 11:53:30 AM
Q Therapeutics, Inc. Invited To Present At The Swedish-American Life Science Summit 2014 8/21/2014 7:59:34 AM
Q Therapeutics, Inc. Announces First U.S. Patent Relating To Fifth Patent Family On Neural Cells 7/7/2014 11:52:45 AM
Q Therapeutics, Inc. To Present At The National Investment Banking Association's 131st Investment Conference 6/10/2014 10:03:24 AM
Q Therapeutics, Inc. Issues Formal Corporate Update 4/22/2014 8:43:53 AM
Mahendra Rao, MD, PhD Joins Q Therapeutics, Inc. As Chief Strategy Officer 4/1/2014 11:11:48 AM